Dr. Fortune Alabi, MD
What this data tells you about Dr. Alabi
Dr. Fortune Alabi is a pulmonary disease in Kissimmee, FL, with 20 years in practice. Based on federal Medicare data, Dr. Alabi performed 5,616 Medicare services across 2,938 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alabi received a total of $559,545 from 72 pharmaceutical and/or device companies across 1974 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alabi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, benralizumab, 1 mg | 1,598 | $132 | $199 |
| Office visit, established patient (30-39 min) | 822 | $91 | $215 |
| Test to measure expiratory airflow and volume | 556 | $20 | $73 |
| Test to determine lung volumes using sensors | 480 | $41 | $109 |
| Test to examine how well the lungs exchange gases | 458 | $43 | $108 |
| Hospital follow-up visit, high complexity | 382 | $95 | $230 |
| Office visit, established patient (20-29 min) | 339 | $67 | $145 |
| Drug injection, under skin or into muscle | 167 | $11 | $100 |
| CT scan of chest, without contrast | 134 | $107 | $290 |
| Hospital follow-up visit, moderate complexity | 110 | $64 | $145 |
| Chest X-ray, 2 views | 89 | $26 | $75 |
| New patient office visit (45-59 min) | 84 | $126 | $334 |
| New patient office visit, complex (60-74 min) | 76 | $163 | $414 |
| Initial hospital admission, high complexity | 69 | $136 | $388 |
| Critical care, first 30-74 min | 43 | $174 | $568 |
| Flu vaccine, high-dose | 38 | $64 | $65 |
| Flu vaccine administration | 37 | $25 | $26 |
| Sleep study in sleep lab (6 years or older) | 28 | $436 | $1,108 |
| Initial hospital admission, moderate complexity | 23 | $105 | $266 |
| Test for exercise-induced lung stress | 20 | $27 | $122 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 19 | $452 | $1,223 |
| Office visit, established patient, complex (40-54 min) | 19 | $137 | $288 |
| Sleep study including heart rate, breathing, and sleep time | 13 | $115 | $518 |
| Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | 12 | $28 | $60 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for pulmonary disease in FL.
Geographic Context
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Alabi is a clinical cardiology specialist, with above-average Medicare volume (top 5% in FL), and high industry engagement (speaking/promotional, top 1%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Alabi experienced with injection, benralizumab, 1 mg?
Does Dr. Alabi receive payments from pharmaceutical companies?
How do Dr. Alabi's costs compare to other pulmonary diseases in Kissimmee?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology